166 filings
Page 2 of 9
6-K
spb88i7
10 Aug 23
GENFIT Announces the Publication of New Data on the Clinical Performance of NIS2+™ in Older Patients in Hepatology Communications
4:10pm
6-K
a0cdmlt7
12 Jul 23
Current report (foreign)
12:00am
6-K
3rokka
30 Jun 23
Current report (foreign)
6:00am
6-K
t4a7iah ajjz5lc86ob
7 Jun 23
GENFIT Announces New Data at the European Association for the Study of the Liver (EASL) Congress 2023
4:10pm
6-K
8qz58
31 May 23
GENFIT Further Strengthens its ACLF Franchise with a Third Clinical-Stage Asset
4:15pm
6-K
kklvof74j1chn25s2ikm
24 May 23
Current report (foreign)
3:00pm
6-K
747rjefuud33
23 May 23
GENFIT Announces Publication of the Development and Validation of NIS2+™ in the Journal of Hepatology
4:10pm
6-K
7swke0fm
11 May 23
GENFIT Reports First Quarter 2023 Financial Information1
4:10pm
6-K
6lcykfs f2abkrbvb
9 May 23
GENFIT Presents Phase 1 Clinical Data Evaluating NTZ at Digestive Disease Week® as part of its ACLF Program
4:10pm
EFFECT
1oqib9 5orn9
5 May 23
Notice of effectiveness
12:16am
CORRESP
8h2r0kmce7 6688
2 May 23
Correspondence with SEC
12:00am
SC 13G
rbg lgz15lrse
1 May 23
Genfit / TANG CAPITAL PARTNERS ownership change
4:00pm
6-K
z40ox375l4x ij
28 Apr 23
GENFIT Announces Publication of Extra-Financial Performance Report 2022
6:00am
UPLOAD
lxp7ee0
25 Apr 23
Letter from SEC
12:00am
6-K
0sylrlby8fa sqqvyz0
19 Apr 23
Current report (foreign)
4:10pm
6-K
wqmd2fvm1khemb
18 Apr 23
GENFIT Announces Publication of the 2022 Universal Registration Document and the 2022 Annual Report on Form 20-F
4:10pm
F-3
2ki1e
18 Apr 23
Shelf registration (foreign)
2:33pm
S-8
ll3cjg3mdj
18 Apr 23
Registration of securities for employees
2:13pm
6-K
pay u0a1dpiquwl
14 Apr 23
GENFIT Reports Full-Year 2022 Financial Results and Provides Corporate Update
7:00am